AI assistant
Devolver Digital, Inc. — Report Publication Announcement 2022
Aug 9, 2022
10468_rpa_2022-08-09_5e5558b9-4051-4292-bd14-c412a254abc8.html
Report Publication Announcement
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 3216V
Devolver Digital, Inc.
09 August 2022
09 August 2022
Devolver Digital, Inc
("Devolver" or the "Company")
Notice of Half Year Results
Devolver Digital, Inc (AIM: DEVO), an award-winning digital publisher and developer of indie video games, will announce half year results for the six months ended 30 June 2022 on Monday 26 September 2022.
Management will host a presentation at FTI Consulting, 200 Aldersgate Street, London EC1A 4HD, at 9.00 AM.
Event details:
Webcast options are not available. This is an in-person event.
RSVP:
If you would like to attend, please RSVP to FTI Consulting at [email protected]
Enquiries
| Devolver Digital, Inc. Harry Miller, Executive Chairman Douglas Morin, Chief Executive Officer Daniel Widdicombe, Chief Financial Officer |
[email protected] |
| Zeus (Nominated Adviser and Broker) Richard Darlington, Daniel Harris (Investment Banking) Benjamin Robertson (Corporate Broking) |
+44 (0)20 3829 5000 |
| FTI Consulting (Communications Adviser) Jamie Ricketts / Dwight Burden / Valerija Cymbal / Usama Ali |
[email protected] +44 (0)20 3727 1000 |
About Devolver Digital
Devolver is an award-winning video games publisher in the indie games space with a balanced portfolio of third-party and own-IP. Devolver has an emphasis on premium games and has published more than 90 titles, with more than 30 titles in the pipeline scheduled for release over the next two years and beyond. Devolver has its own-IP franchises, in-house studios developing first-party IP and a complementary publishing brand. Devolver is registered in Wilmington, Delaware, USA.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NORSSDFWAEESEFA